| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c35f3a3c112c482bcfa47356c4f80c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06N3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H30-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-40 |
| filingDate |
2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c9851f329f68dfc93c208300a467e59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2eaf82af13aac16fab02a39cb706f7b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96309a36689b6222f8e48620f3cff6aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_677c9e9242d68a8f29bf905b3064ceaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9afe7449bd1b879dc7bd4ac0471ccc68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_812d0ae68bbcd531767ef54d03135512 |
| publicationDate |
2022-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022223261-A1 |
| titleOfInvention |
Identification of candidate signs indicative of an ntrk oncogenic fusion |
| abstract |
The present invention relates to the identification of one or more candidate signs indicative of an NTRK oncogenic fusion within patient data. Subject matter of the present invention are a computer-implemented method, a system, and a non-transitory computer-readable storage medium for determining a probability value from patient data associated with a subject patient, the probability value indicating the probability of the subject patient suffering from cancer caused by a mutation of a neurotrophic receptor tyrosine kinase (NTRK) gene. |
| priorityDate |
2019-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |